TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells

We have previously observed that tropomyosin receptor kinase B (TrkB) induces breast cancer metastasis by activating both the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) and phosphatidylinositol-3-Kinase (PI3K)/AKT signaling pathways and inhibiting runt-related tra...

Full description

Bibliographic Details
Main Authors: Min Soo Kim, Wook Jin
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/8/2095
_version_ 1797561092855037952
author Min Soo Kim
Wook Jin
author_facet Min Soo Kim
Wook Jin
author_sort Min Soo Kim
collection DOAJ
description We have previously observed that tropomyosin receptor kinase B (TrkB) induces breast cancer metastasis by activating both the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) and phosphatidylinositol-3-Kinase (PI3K)/AKT signaling pathways and inhibiting runt-related transcription factor 3 (RUNX3) and kelch-like ECH-associated protein 1 (KEAP1). These studies indicated that TrkB expression is crucial to the pathogenesis of breast cancer. However, how TrkB regulates bone morphogenetic protein (BMP) signaling and tumor suppression is largely unknown. Herein, we report that TrkB is a key regulator of BMP-mediated tumor suppression. TrkB enhances the metastatic potential of cancer cells by promoting cell anchorage-independent growth, migration, and suppressing BMP-2-mediated growth inhibition. TrkB inhibits the BMP-mediated activation of SMAD family member 1 (SMAD1) by promoting the formation of the TrkB/BMP type II receptor complex and suppresses RUNX3 by depleting BMP receptor I (BMPRI) expression. In addition, the knockdown of TrkB restored the tumor-inhibitory effect of BMP-2 via the activation of SMAD1. Moreover, the TrkB kinase activity was required for its effect on BMP signaling. Our study identified a unique role of TrkB in the regulation of BMP-mediated growth inhibition and BMP-2-induced RUNX3 expression.
first_indexed 2024-03-10T18:09:24Z
format Article
id doaj.art-b239e590bb104b3dbe6df65ce7bba20b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T18:09:24Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-b239e590bb104b3dbe6df65ce7bba20b2023-11-20T08:13:48ZengMDPI AGCancers2072-66942020-07-01128209510.3390/cancers12082095TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer CellsMin Soo Kim0Wook Jin1Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, Gachon University, Incheon 21999, KoreaLaboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, Gachon University, Incheon 21999, KoreaWe have previously observed that tropomyosin receptor kinase B (TrkB) induces breast cancer metastasis by activating both the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) and phosphatidylinositol-3-Kinase (PI3K)/AKT signaling pathways and inhibiting runt-related transcription factor 3 (RUNX3) and kelch-like ECH-associated protein 1 (KEAP1). These studies indicated that TrkB expression is crucial to the pathogenesis of breast cancer. However, how TrkB regulates bone morphogenetic protein (BMP) signaling and tumor suppression is largely unknown. Herein, we report that TrkB is a key regulator of BMP-mediated tumor suppression. TrkB enhances the metastatic potential of cancer cells by promoting cell anchorage-independent growth, migration, and suppressing BMP-2-mediated growth inhibition. TrkB inhibits the BMP-mediated activation of SMAD family member 1 (SMAD1) by promoting the formation of the TrkB/BMP type II receptor complex and suppresses RUNX3 by depleting BMP receptor I (BMPRI) expression. In addition, the knockdown of TrkB restored the tumor-inhibitory effect of BMP-2 via the activation of SMAD1. Moreover, the TrkB kinase activity was required for its effect on BMP signaling. Our study identified a unique role of TrkB in the regulation of BMP-mediated growth inhibition and BMP-2-induced RUNX3 expression.https://www.mdpi.com/2072-6694/12/8/2095TrkBbone morphogenetic proteins (BMPs)BMP type I (BMPRI) and BMP type II (BMPRII) receptortumor suppressor activitytumor progression
spellingShingle Min Soo Kim
Wook Jin
TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
Cancers
TrkB
bone morphogenetic proteins (BMPs)
BMP type I (BMPRI) and BMP type II (BMPRII) receptor
tumor suppressor activity
tumor progression
title TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
title_full TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
title_fullStr TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
title_full_unstemmed TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
title_short TrkB Inhibits the BMP Signaling-Mediated Growth Inhibition of Cancer Cells
title_sort trkb inhibits the bmp signaling mediated growth inhibition of cancer cells
topic TrkB
bone morphogenetic proteins (BMPs)
BMP type I (BMPRI) and BMP type II (BMPRII) receptor
tumor suppressor activity
tumor progression
url https://www.mdpi.com/2072-6694/12/8/2095
work_keys_str_mv AT minsookim trkbinhibitsthebmpsignalingmediatedgrowthinhibitionofcancercells
AT wookjin trkbinhibitsthebmpsignalingmediatedgrowthinhibitionofcancercells